AYTU BIOPHARMA, INC — Director's Dealing 2021

Apr 6, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AYTU BIOPHARMA, INC (AYTU)
CIK: 0001385818
Period of Report: 2021-03-31

Reporting Person: Eisenstadt Richard I (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001	13734	Direct

Footnotes

F1: Includes 6,358 shares issued as restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of AYTU common stock. The RSUs vest as follows, and have no voting or dispositive rights until vested: 408 RSUs vest on May 21, 2021; 510 RSUs vest on March 1, 2022, and 5,440 RSUs vest on March 2, 2022, subject to the reporting person's continuing employment with the Issuer.